Free Trial

2,267 Shares in CME Group Inc. (NASDAQ:CME) Bought by 49 Wealth Management LLC

CME Group logo with Finance background

49 Wealth Management LLC bought a new position in CME Group Inc. (NASDAQ:CME - Free Report) during the first quarter, according to its most recent disclosure with the SEC. The firm bought 2,267 shares of the financial services provider's stock, valued at approximately $602,000.

A number of other institutional investors also recently bought and sold shares of the stock. Wayfinding Financial LLC bought a new stake in CME Group during the first quarter valued at about $25,000. Golden State Wealth Management LLC raised its holdings in CME Group by 612.5% during the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock valued at $30,000 after acquiring an additional 98 shares during the period. Alpine Bank Wealth Management bought a new stake in CME Group during the first quarter valued at about $32,000. New Age Alpha Advisors LLC raised its holdings in CME Group by 50.0% during the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock valued at $30,000 after acquiring an additional 43 shares during the period. Finally, Knuff & Co LLC bought a new stake in CME Group during the fourth quarter valued at about $33,000. 87.75% of the stock is owned by institutional investors.

Insider Buying and Selling

In other CME Group news, Director Phyllis M. Lockett sold 1,060 shares of the business's stock in a transaction that occurred on Monday, May 19th. The stock was sold at an average price of $277.88, for a total transaction of $294,552.80. Following the completion of the transaction, the director owned 3,108 shares in the company, valued at $863,651.04. The trade was a 25.43% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Derek Sammann sold 4,650 shares of the business's stock in a transaction that occurred on Monday, May 5th. The shares were sold at an average price of $280.61, for a total value of $1,304,836.50. Following the transaction, the insider owned 8,336 shares of the company's stock, valued at $2,339,164.96. This trade represents a 35.81% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 13,400 shares of company stock valued at $3,680,610 in the last quarter. 0.30% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on CME shares. Royal Bank Of Canada reissued a "sector perform" rating and set a $269.00 price target on shares of CME Group in a report on Thursday, April 3rd. Raymond James Financial raised CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price target on the stock in a report on Monday, March 10th. Citigroup raised their price target on CME Group from $265.00 to $275.00 and gave the company a "neutral" rating in a report on Thursday, July 3rd. Piper Sandler raised their price objective on CME Group from $275.00 to $283.00 and gave the company an "overweight" rating in a research report on Tuesday, April 8th. Finally, Barclays raised their price objective on CME Group from $279.00 to $283.00 and gave the company an "equal weight" rating in a research report on Wednesday, April 23rd. Three equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and five have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $259.87.

Get Our Latest Report on CME Group

CME Group Trading Up 2.1%

CME opened at $282.55 on Tuesday. The firm has a market cap of $101.82 billion, a P/E ratio of 28.43, a P/E/G ratio of 3.75 and a beta of 0.44. CME Group Inc. has a 12 month low of $193.17 and a 12 month high of $290.79. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The stock has a 50-day moving average of $276.69 and a 200 day moving average of $258.49.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, topping the consensus estimate of $2.61 by $0.19. The company had revenue of $1.64 billion during the quarter, compared to analyst estimates of $1.56 billion. CME Group had a return on equity of 14.03% and a net margin of 57.71%. The firm's revenue was up 10.4% on a year-over-year basis. During the same quarter last year, the business posted $2.50 earnings per share. As a group, research analysts forecast that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, June 25th. Investors of record on Monday, June 9th were given a $1.25 dividend. The ex-dividend date was Monday, June 9th. This represents a $5.00 annualized dividend and a yield of 1.77%. CME Group's dividend payout ratio is currently 50.30%.

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

See Also

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Made in America Stocks Under $20 You Need to See!
3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines